CATEGORIES

Gavi and India join hands to protect children with life-saving vaccines
BioSpectrum Asia

Gavi and India join hands to protect children with life-saving vaccines

Gavi, the Vaccine Alliance, and the Government of India have established a new three-year partnership that aims to reach millions of children in the country with life-saving vaccines.

time-read
1 min  |
BioSpectrum Asia March 2023
China approves AI software to assess symptoms of Parkinson's disease
BioSpectrum Asia

China approves AI software to assess symptoms of Parkinson's disease

Nervtex's MoDAS artificial intelligence (AI) system has become the first video-based, AI-powered medical device to win regulatory approval for assessing motor symptoms in Parkinson's disease and other movement disorders, according to a company press release.

time-read
1 min  |
BioSpectrum Asia March 2023
APAC Fem Tech Space Gains Momentum
BioSpectrum Asia

APAC Fem Tech Space Gains Momentum

Do you know what takes the blame for a woman’s bad health? Oestrogen, as it is the hormone that plays a central role in women’s health.

time-read
10+ mins  |
BioSpectrum Asia March 2023
Can India Eliminate TB by 2025?
BioSpectrum Asia

Can India Eliminate TB by 2025?

Tuberculosis (TB) is a severe public health issue in India, accounting for a quarter of the global TB burden.

time-read
5 mins  |
BioSpectrum Asia March 2023
How Imaging Tech And Liquid Biopsy Will Play Pivotal Role In Cancer Care
BioSpectrum Asia

How Imaging Tech And Liquid Biopsy Will Play Pivotal Role In Cancer Care

A core tenet of precision medicine is to simplify the delivery of the right treatment to the right patient at the right dose and at the right time.

time-read
5 mins  |
BioSpectrum Asia Feb 2023
Sartorius & RoosterBio to advance downstream purification for exosomes manufacturing
BioSpectrum Asia

Sartorius & RoosterBio to advance downstream purification for exosomes manufacturing

Germany-headquartered Sartorius has extended a strategic collaboration partnership agreement with US-based RoosterBio to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Qiagen launches EZ2 Connect MDx platform for automated sample processing in diagnostic labs
BioSpectrum Asia

Qiagen launches EZ2 Connect MDx platform for automated sample processing in diagnostic labs

Qiagen has announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the in vitro diagnostic (IVD) platform for automated sample processing available for wide scale use 18 months after being made available for research.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution
BioSpectrum Asia

Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution

Japan-headquartered Shimadzu Corporation has announced the release of the world’s smallest MALDI-TOF imaging solution, available as an option on the successful benchtop MALDI-TOF mass spectrometry series: the MALDI-8020 for positive ion analysis and the MALDI-8030, which features a dual-polarity ion source.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Thermo Fisher unveils CE-IVD marked assay to detect treatment-resistant HIV-1 strains
BioSpectrum Asia

Thermo Fisher unveils CE-IVD marked assay to detect treatment-resistant HIV-1 strains

Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Study in NZ, Australia set to change treatment of children with acute respiratory problems
BioSpectrum Asia

Study in NZ, Australia set to change treatment of children with acute respiratory problems

A world-first Australian and New Zealand (NZ) study is set to change how clinicians treat children with acute respiratory problems, improving best care and potentially saving millions of healthcare dollars, particularly in remote, rural and indigenous communities.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Korea provides new equation to US FDA for improving drug interaction prediction
BioSpectrum Asia

Korea provides new equation to US FDA for improving drug interaction prediction

The US Food and Drug Administration (FDA) recommends indirect evaluation of drug interactions using a formula suggested in their guidance first published in 1997, revised in January of 2020, in order to evaluate drug interactions and minimise side effects of having to use more than one type of drugs at once.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Singapore demonstrates quantum recoil, paving way for precise X-ray imaging in healthcare
BioSpectrum Asia

Singapore demonstrates quantum recoil, paving way for precise X-ray imaging in healthcare

For the first time since it was proposed over 80 years ago, scientists from Nanyang Technological University, Singapore (NTU Singapore) have demonstrated the phenomenon of \"quantum recoil\", which describes how the particle nature of light has a major impact on electrons moving through materials.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Australia turns back the clock on damaged heart tissue
BioSpectrum Asia

Australia turns back the clock on damaged heart tissue

An international team of researchers, led by University of Sydney in Australia, has developed a method to reverse the loss of elasticity of damaged heart tissue following heart attacks.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board
BioSpectrum Asia

Former FDA medical device officer joins Pulnovo Medical's scientific advisory board

China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company’s Scientific Advisory Board (SAB).

time-read
1 min  |
BioSpectrum Asia Feb 2023
SK Bioscience accelerates global growth strategy by picking talent from Big Pharma
BioSpectrum Asia

SK Bioscience accelerates global growth strategy by picking talent from Big Pharma

South Korea-based SK bioscience has announced that Richard Kensinger, PhD, former Director and Head of Drug Substance Process Development in SanofiPasteur and former Executive Director of Process Development and Protein Sciences at Affinivax Inc. has joined in ‘SK bioscience USA Inc.’ as Vice President of R&D Project Management. Dr Kensinger is an expert who has been dedicated to biopharmaceutical R&D, working at global companies for more than 20 years.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Dr David John Jeans steps in as HistoIndex's Non-Executive Chairman
BioSpectrum Asia

Dr David John Jeans steps in as HistoIndex's Non-Executive Chairman

Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Rockwell appoints Mariya Prempeh Singapore Country Manager
BioSpectrum Asia

Rockwell appoints Mariya Prempeh Singapore Country Manager

Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer
BioSpectrum Asia

Asieris Pharma appoints Dr Linda Wu as Chief Development Officer

Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising innovative drugs for the treatment of genitourinary tumours and other related diseases, has announced that Linda Wu, PhD will join Asieris as Chief Development Officer.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Chaitanya Sarawate steps in as India MD for Wipro GE Health Care
BioSpectrum Asia

Chaitanya Sarawate steps in as India MD for Wipro GE Health Care

Wipro GE HealthCare has announced the appointment of Chaitanya Sarawate as the Managing Director (MD), Wipro GE HealthCare and President & CEO, GE HealthCare South Asia.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Goa Institute of Management launches professional certificate programme in healthcare
BioSpectrum Asia

Goa Institute of Management launches professional certificate programme in healthcare

Goa Institute of Management (GIM) in India has launched a Professional Certificate Programme in Healthcare Management powered by Asia’s largest higher Edtech Company, upGrad.

time-read
1 min  |
BioSpectrum Asia Feb 2023
Singapore unveils talent development strategy to boost Healthtech and Biotech ecosystem
BioSpectrum Asia

Singapore unveils talent development strategy to boost Healthtech and Biotech ecosystem

Considering Singapore’s RIE2025 initiative, SGInnovate’s Helix Immersion Programme will support Singapore’s growing biomedical and biotech companies.

time-read
1 min  |
BioSpectrum Asia Feb 2023
VALUE is the Trending Word of 2023
BioSpectrum Asia

VALUE is the Trending Word of 2023

The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. although this next iteration will focus on leveraging the industry's growing digital maturity to offer increased patient value while achieving measurable business goals.

time-read
5 mins  |
BioSpectrum Asia Feb 2023
"Australia is poised to establish itself as a global life sciences hub"
BioSpectrum Asia

"Australia is poised to establish itself as a global life sciences hub"

Synthetic biology markets are experiencing a surge in demand for molecular diagnostics and technological advances in molecular biology, spurring growth in the Assay and Reagent market in Asia Pacific.

time-read
4 mins  |
BioSpectrum Asia Feb 2023
"We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"
BioSpectrum Asia

"We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"

Rare diseases remain untreatable globally despite major advances in research that have enabled us to understand their molecular basis, as well as legislation that provides regulatory and economic incentives to encourage their development.

time-read
5 mins  |
BioSpectrum Asia Feb 2023
"Global investors can leverage our deep immunomics platform to develop TCR Cell therapies for solid tumours"
BioSpectrum Asia

"Global investors can leverage our deep immunomics platform to develop TCR Cell therapies for solid tumours"

The global biotech ecosystem continues to fluctuate and pose fresh challenges but many emerging enterprises and technologies are keen to collaborate with other stakeholders to solve healthcare challenges.

time-read
5 mins  |
BioSpectrum Asia Feb 2023
"We need to foster risky projects that can have large rewards"
BioSpectrum Asia

"We need to foster risky projects that can have large rewards"

Synthetic lethality is a promising area of cancer therapy. Anticancer Bioscience (ACB) is a precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies.

time-read
4 mins  |
BioSpectrum Asia Feb 2023
"Technology will play a significant role in reducing numbers of new cases and deaths"
BioSpectrum Asia

"Technology will play a significant role in reducing numbers of new cases and deaths"

‘Close the care gaps’ – a bold theme set for 2022-2024 World Cancer Day campaigns that fall on February 4 each year – intends to make a huge difference in delivering cancer care to the people.

time-read
5 mins  |
BioSpectrum Asia Feb 2023
CANCER THERAPEUTICS GAINING GROUND IN APAC
BioSpectrum Asia

CANCER THERAPEUTICS GAINING GROUND IN APAC

Cancer, the leading cause of death in most parts of the world, is a veritable Achilles heel for the pharma industry.

time-read
10+ mins  |
BioSpectrum Asia Feb 2023
Addressing Unmet Patient Needs in Antimicrobial Resistance (AMR): The Vital Role of Industry Partnerships
BioSpectrum Asia

Addressing Unmet Patient Needs in Antimicrobial Resistance (AMR): The Vital Role of Industry Partnerships

Interview- Mr Maurizio Luongo and Mr Zhao Hong

time-read
6 mins  |
BioSpectrum Asia Feb 2023
Veradigm announces strategic investment in Holmusk from Singapore
BioSpectrum Asia

Veradigm announces strategic investment in Holmusk from Singapore

US-based Veradigm has announced an investment in Holmusk, a global behavioural health real-world evidence and data analytics company in Singapore, as part of Holmusk’s $45 million series B financing round.

time-read
1 min  |
BioSpectrum Asia Feb 2023